temozolomide
not tagged
['sclc', 'lcsm,(-blcsm)', 'temozolomide']
exciting data - 40% (!) response rates in relapsed sclc is a win. especially when it is with two oral drugs (one of which -- temozolomide -- has established activity in brain mets and is in the #sclc nccn guidelines). #asco22 #lcsm (images from tala/tmz goldman et al poster) 
Medical oncologist @MDAndersonNews. Researching #lungcancer #sclc and DNA damage repair inhibitors #cancer #oncology #endcancer. Tweets are my own.